Privia Health Q3 revenue up 32.5%, raises FY forecast

Privia Health

06/11/2025 11:14

Overview

Privia Health Q3 revenue grows 32.5% yr/yr but misses analyst expectations

Adjusted EBITDA for Q3 beats consensus

Company raises FY'25 guidance above high end for key metrics

Outlook

Privia Health raises FY'25 revenue guidance to $2.05 bln-$2.1 bln

Company expects FY'25 adjusted EBITDA of $118 mln-$121 mln

Privia Health anticipates ending FY'25 with at least $410 mln in cash

Result Drivers

VALUE-BASED CARE - Strong results in Medicare Shared Savings Program and other value-based care arrangements contributed to Q3 performance

PRACTICE COLLECTIONS - Practice collections increased 27.1% compared to 3Q’24, supporting revenue growth

PROVIDER GROWTH - Implemented providers grew 13.1% compared to 3Q’24, enhancing service capacity

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Miss
$580.40 mln
$781.95 mln (12 Analysts)
Q3 EPS
$0.05
Q3 Net Income
$6.90 mln
Q3 Adjusted EBITDA
Beat
$38.20 mln
$28.15 mln (16 Analysts)
Q3 Operating Income
$14.40 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 18 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the healthcare facilities & services peer group is "buy"

Wall Street's median 12-month price target for Privia Health Group Inc is $30.50, about 18% above its November 5 closing price of $25.02

The stock recently traded at 85 times the next 12-month earnings vs. a P/E of 70 three months ago

Press Release: ID:nGNX2BBcSj

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)